Emmaus Life Sciences, Inc. has filed 1,247 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| 8-K | 2026-05-15 | Results of Operations and Financial Condition; Financial Statements and Exhibits |
| 10-Q | 2026-05-15 | Quarterly Report |
| 3 | 2026-04-21 | Initial Statement of Beneficial Ownership |
| 8-K | 2026-04-17 | Departure/Appointment of Directors or Officers; Financial Statements and Exhibits |
| 8-K | 2026-04-14 | Departure/Appointment of Directors or Officers; Financial Statements and Exhibits |
| 10-K | 2026-03-31 | Annual Report |
| 8-K | 2026-03-31 | Results of Operations and Financial Condition; Financial Statements and Exhibits |
| 8-K | 2026-03-04 | Entry into a Material Definitive Agreement; Financial Statements and Exhibits |
| 8-K | 2025-12-31 | Entry into a Material Definitive Agreement; Other Events |
| 8-K | 2025-12-22 | Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation |